Citigroup’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.4M | Sell |
138,451
-278,168
| -67% | -$4.82M | ﹤0.01% | 1897 |
|
|
2025
Q1 | $9.11M | Buy |
416,619
+224,458
| +117% | +$4.91M | ﹤0.01% | 1031 |
|
|
2024
Q4 | $6.13M | Buy |
192,161
+179,999
| +1,480% | +$5.74M | ﹤0.01% | 1259 |
|
|
2024
Q3 | $351K | Sell |
12,162
-30,507
| -71% | -$880K | ﹤0.01% | 3220 |
|
|
2024
Q2 | $1.64M | Sell |
42,669
-219,039
| -84% | -$8.4M | ﹤0.01% | 1903 |
|
|
2024
Q1 | $15.4M | Buy |
261,708
+175,167
| +202% | +$10.3M | 0.01% | 728 |
|
|
2023
Q4 | $5.18M | Sell |
86,541
-30,355
| -26% | -$1.82M | ﹤0.01% | 1112 |
|
|
2023
Q3 | $4.45M | Buy |
116,896
+36,911
| +46% | +$1.4M | ﹤0.01% | 1091 |
|
|
2023
Q2 | $7.29M | Sell |
79,985
-43,422
| -35% | -$3.96M | ﹤0.01% | 936 |
|
|
2023
Q1 | $8.14M | Buy |
123,407
+41,307
| +50% | +$2.72M | 0.01% | 920 |
|
|
2022
Q4 | $4.25M | Sell |
82,100
-15,732
| -16% | -$814K | ﹤0.01% | 1125 |
|
|
2022
Q3 | $6.68M | Sell |
97,832
-4,128
| -4% | -$282K | ﹤0.01% | 975 |
|
|
2022
Q2 | $4.61M | Buy |
101,960
+75,276
| +282% | +$3.4M | ﹤0.01% | 1159 |
|
|
2022
Q1 | $1.36M | Sell |
26,684
-93,004
| -78% | -$4.73M | ﹤0.01% | 2075 |
|
|
2021
Q4 | $5.66M | Buy |
119,688
+49,396
| +70% | +$2.34M | ﹤0.01% | 1210 |
|
|
2021
Q3 | $2.32M | Sell |
70,292
-22,436
| -24% | -$740K | ﹤0.01% | 1803 |
|
|
2021
Q2 | $5.86M | Sell |
92,728
-5,346
| -5% | -$338K | ﹤0.01% | 1323 |
|
|
2021
Q1 | $4.21M | Buy |
98,074
+2,888
| +3% | +$124K | ﹤0.01% | 1440 |
|
|
2020
Q4 | $5.45M | Buy |
95,186
+85,979
| +934% | +$4.92M | ﹤0.01% | 1219 |
|
|
2020
Q3 | $278K | Sell |
9,207
-58,578
| -86% | -$1.77M | ﹤0.01% | 2595 |
|
|
2020
Q2 | $2.21M | Buy |
67,785
+15,336
| +29% | +$501K | ﹤0.01% | 1562 |
|
|
2020
Q1 | $1.41M | Sell |
52,449
-28,587
| -35% | -$766K | ﹤0.01% | 1589 |
|
|
2019
Q4 | $2.48M | Buy |
81,036
+45,113
| +126% | +$1.38M | ﹤0.01% | 1544 |
|
|
2019
Q3 | $865K | Sell |
35,923
-11,099
| -24% | -$267K | ﹤0.01% | 2223 |
|
|
2019
Q2 | $1.19M | Buy |
47,022
+23,547
| +100% | +$596K | ﹤0.01% | 2011 |
|
|
2019
Q1 | $458K | Sell |
23,475
-27,438
| -54% | -$535K | ﹤0.01% | 2571 |
|
|
2018
Q4 | $672K | Buy |
50,913
+3,386
| +7% | +$44.7K | ﹤0.01% | 2288 |
|
|
2018
Q3 | $845K | Buy |
47,527
+20,301
| +75% | +$361K | ﹤0.01% | 2126 |
|
|
2018
Q2 | $599K | Buy |
27,226
+27,206
| +136,030% | +$599K | ﹤0.01% | 2215 |
|
|
2018
Q1 | $0 | Sell |
20
-1,200
| -98% | – | ﹤0.01% | 4895 |
|
|
2017
Q4 | $26K | Buy |
+1,220
| New | +$26K | ﹤0.01% | 4125 |
|